Biosimilars are becoming indispensable in the management of multiple diseases although concerns still exist

Authors

  • Brian Godman Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, GlasgowG4 0RE, United Kingdom

DOI:

https://doi.org/10.3329/bjms.v20i1.50338

Keywords:

Adalimumab; biosimilars; demand-side measures; generics; insulin glargine; savings

Abstract

Abstract Not Available

Bangladesh Journal of Medical Science Vol.20(1) 2021 p.5-10

Downloads

Download data is not yet available.
Abstract
497
PDF
789

Downloads

Published

2021-01-01

How to Cite

Godman, B. (2021). Biosimilars are becoming indispensable in the management of multiple diseases although concerns still exist. Bangladesh Journal of Medical Science, 20(1), 5–10. https://doi.org/10.3329/bjms.v20i1.50338

Issue

Section

Editorial